The particulars: hair thinning · six · dulaglutide.
I am trying to do this correctly the first time rather than learn it by getting it wrong.
I have already made one mistake here that cost me a vial, so I am being deliberately careful.
What is the correct sequence, and where is the step that people usually skip?
Week 6 is day 42: on a four-week ladder that is week 2 of dose step 2, and — at the seven-day half-life this class runs on — 6 half-lives in. Steady state is about five half-lives, so day 35 is where the concentration stops climbing on its own. Day 42 is 1 weeks past it, which means the level is no longer the variable. That distinction is most of the question: at week 2 of a step, an effect that is still accumulating is indistinguishable from one that is not resolving unless you know which side of day 35 you are on. Telogen effluvium lags its trigger by roughly three months, which is twelve weeks. Week 6 therefore points at about week 0 as the trigger — which is before the first dose, so the deficit and the agent are not the only candidates and probably not the first ones. Dose decisions are made under supervision, and nothing here is medical advice.
Answering this needs the rate of weight loss and the protein intake, since those are the two modifiable contributors.
The trigger in this context is the rate of weight loss and the associated nutritional deficit, not a pharmacological property. The same phenomenon is well documented after bariatric surgery, illness and childbirth.
Put another way, adequate protein matters. Hair is largely keratin, and follicles are among the most metabolically active tissues, so they are early casualties of a substantial protein shortfall.
The two-to-four-month latency follows directly from the duration of the telogen phase and is the diagnostic feature of the condition.
It resolves in most cases over six to twelve months. That is genuinely the answer.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemSpecifically, this is one of the most distressing reported effects and one of the most reliably temporary.
Recovery follows the same timeline in reverse: shedding stops within a few months of the trigger resolving, and visible density returns over six to twelve months as regrowth reaches length.
Worth checking: ferritin, thyroid function and vitamin D. Low ferritin in particular is associated with shedding at levels that are not low enough to cause anaemia.
Recovery of density over six to twelve months is the typical reported course where the trigger has resolved.
Diffuse and delayed means telogen effluvium. Patterned means something else.
Iron, thyroid and vitamin D are the checks worth doing before concluding anything.
Slowing the rate of weight loss reduces the severity of the trigger. It does not reverse a shed already in progress, because the follicles have already committed.
It is diffuse: increased shedding across the whole scalp, often noticed in the shower or on a brush, without a receding hairline or a defined crown pattern. Patterned loss is androgenetic and unrelated.
Telogen effluvium following rapid weight loss is well documented in the dermatological literature, including extensive description after bariatric surgery.
The trigger is the rate of loss, not the compound. Slowing it helps future follicles.
edited 26 Sept 2025 by Dr_Hanne_Solberg — updated for the 2026 guidance change
It helps to be literal here: patterned rather than diffuse loss is a different condition and points elsewhere.
Nothing topical has strong evidence for accelerating recovery from telogen effluvium specifically, as distinct from androgenetic loss where the evidence is entirely different.
Low ferritin is associated with increased shedding in observational studies at thresholds above those used to define anaemia.
Nothing here is medical advice.
Check ferritin, thyroid and vitamin D once, then stop investigating.
Start with the timing, because telogen effluvium has a characteristic delay of two to four months between the trigger and the shed.
In telogen effluvium a stressor shifts a large fraction of follicles from anagen into telogen simultaneously. Because telogen lasts around two to three months, the shed appears two to four months after the trigger rather than during it.
The pooled gastrointestinal adverse-event rates across the STEP programme and the SURMOUNT programme are reported in the primary publications and in the FDA and EMA assessment reports, and the assessment reports are more useful because they give the placebo-arm rates alongside the active-arm rates in the same table.
Supplementing without a measured deficiency has no evidence behind it here and is not harmless at high doses.
Protein intake is the modifiable nutritional factor worth attending to.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.